Navigation Links
Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
Date:4/9/2009

peutics: Tolera Therapeutics is a Kalamazoo, Michigan based biotechnology company and a spin-off of the Cleveland Clinic Foundation. Primary investors in the company include Southwest Michigan First Life Sciences Fund, Triathlon Medical Venture Partners, Hopen Therapeutics and the Michigan Economic Development Corporation. Building upon research done at the University of Kentucky and the Cleveland Clinic, Tolera Therapeutics is developing and commercializing therapies for the immune modulation market with the goal of addressing unmet medical needs with safer, more targeted solutions to reduce the risk of serious and toxic side effects often associated with immunotherapy. The company is focusing on commercializing therapeutic monoclonal antibody technology for the transplantation and autoimmune markets. Additional information concerning the company and its technology can be found on its website www.tolera.com.


'/>"/>
SOURCE Tolera Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
2. Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
3. Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411
4. Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated
5. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
6. Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on Zero Tolerance for Hepatitis B
7. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
8. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
9. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... An interdisciplinary team of researchers led by Northeastern ... constructing precise inter-nanotube junctions and a variety of ... is facile and easily scalable, which will allow ... nanotube networks for use in applications ranging from ... everything from cars to sports equipment. , Their ...
(Date:9/15/2014)... , Sept. 15, 2014 The chemistry, taste, ... climate, says a new article published by the nonprofit American ... PhD, on climate change and its effects on the phytochemical ... an extensive study conducted by Dr. Ahmed in the ... and has implications for the future of medicinal ...
(Date:9/15/2014)... , Sept. 15, 2014  The second annual ... celebrated October 12-18. A joint initiative of the ... member companies , IPAW is designed to: ... , Recognize the contributions of plasma donors in saving ... plasma protein therapies and rare diseases ...
(Date:9/13/2014)... September 13, 2014 Boehringer Laboratories Inc., ... is proud to announce the successful broadcast of a ... surgeons Leonardo Claros, MD, FACS, FAMBS, and Maher El ... Gastrectomy Calibration System. , This sleeve gastrectomy surgery ... of more than four hundred surgeons from around the ...
Breaking Biology Technology:Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 2International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 3Boehringer Laboratories, Inc. Announces Live Surgery Using Innovative System to Calibrate Sleeve Gastrectomy 2
... Dec. 20 Northwest,Biotherapeutics, Inc. (OTC Bulletin ... ("NWBT") announced today that Lonza Group AG ... NWBT,s DCVax(R)-Brain,product and other NWBT DCVax(R) products ... DCVax(R) cancer vaccine products infringed,certain gene expression ...
... teens and adults, HIGHLANDS RANCH, Colo., Dec. 19 ... its treatment services to,include a detox program. The new ... adults, and the hospital has added several new physicians ... abuse and,mental illness)., Teen suicide rates nationally are ...
... PALO ALTO, Calif., Dec. 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... V. Barron, MD, FACC to its Board of Directors. ... Medical Officer at Genentech,where he leads the Development organization, ... Dr. Barron joined Genentech in 1996 as a clinical ...
Cached Biology Technology:Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 2Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 3Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 4Highlands Behavioral Health Hospital Unveils New Substance Abuse Detox Program 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 3
(Date:9/15/2014)... an unprecedented evolution experiment scientists from GEOMAR Helmholtz ... Institute of Sea Fisheries have demonstrated for the ... algae of the world,s oceans, Emiliania huxleyi ... rising water temperatures. In their study, the researchers ... evolutionary adaptations to these two aspects of climate ...
(Date:9/15/2014)... Ebola virus outbreak in West Africa, which has claimed ... a deeper understanding of the molecular biology of the ... vaccines or antiviral drugs to treat or prevent Ebola ... Virginia (UVA), USA under the leadership of Dr ... structural biologist has obtained the crystal structure of ...
(Date:9/15/2014)... September 15, 2014 Schizophrenia is generally considered to ... many risk factors, both genetic and environmental, with other ... The normal path for brain development is determined by ... and a wide range of environmental factors. , However, ... populations are required in order to map the disturbances ...
Breaking Biology News(10 mins):Small algae with great potential 2Small algae with great potential 3Protein secrets of Ebola virus 2Brain Development in Schizophrenia Strays from the Normal Path 2
... AUSTIN, Texas , April 17, 2013 Vermillion, ... company focused on gynecologic cancers and women,s health, announced the ... with the U.S. Army Medical Research and Materiel Command ... titled, "Cost Reduction Using OVA1 in a Treatment Algorithm ...
... Recent developments in postharvest disease control will be highlighted at ... sponsored by the University of California, Riverside Extension ... run from 8 a.m. to 5 p.m. Tuesday, April 23, and ... Santa Barbara . This year,s conference will include a large ...
... Committee for the Asian hornet, the Vespa velutina ... Community (region), the Charter Provincial Councils, the Beekeeping sector ... aimed at controlling the Vespa velutina populations ... an invasive species from France that preys on bees ...
Cached Biology News:U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 2U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 3U.S. Army and Vermillion to Assess Health and Economic Benefits of OVA1 as a Standard of Care 4Conference to highlight latest in postharvest pest control 2
... microPET 220 utilizes utilizies CTI ... leading to superior resolution, sensitivty, and ... the user the flexibility to image ... iamge quality., microPET is a dedicated ...
... been developed to significantly increase the shelf ... Stability is increased at room temperature storage ... This product is subjected to 0.2 micron ... This formulation insures consistently high levels ...
384 Well PCR Plate Carrier for Thermo-Sealer...
... Bead Separation is a powerful tool for ... Typical applications are DNA/RNA or protein purification ... has been fully automated on the Genesis ... Te-MagS. ,In combination with the RoMa ...
Biology Products: